Targeting of HER2-Expressing Tumors with a...

Journal of Nuclear Medicine 2009 / 05 Vol. 50; Iss. 5

Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine

Ahlgren, S., Wallberg, H., Tran, T. A., Widstrom, C., Hjertman, M., Abrahmsen, L., Berndorff, D., Dinkelborg, L. M., Cyr, J. E., Feldwisch, J., Orlova, A., Tolmachev, V.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.108.056929
Date:
May, 2009
File:
PDF, 693 KB
english, 2009
Conversion to is in progress
Conversion to is failed